Geode Capital Management, LLC Innoviva, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,357,557 shares of INVA stock, worth $23.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,357,557
Previous 1,344,300 0.99%
Holding current value
$23.5 Million
Previous $22 Million 18.84%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$16.33 - $20.04 $216,486 - $265,670
13,257 Added 0.99%
1,357,557 $26.2 Million
Q2 2024

Aug 09, 2024
BUY
$14.4 - $16.4 $271,684 - $309,418
18,867 Added 1.42%
1,344,300 $22 Million
Q1 2024

May 13, 2024
BUY
$14.56 - $16.78 $206,184 - $237,621
14,161 Added 1.08%
1,325,433 $20.2 Million
Q4 2023

Feb 13, 2024
BUY
$12.32 - $16.27 $472,780 - $624,361
38,375 Added 3.01%
1,311,272 $21 Million
Q3 2023

Nov 13, 2023
BUY
$12.37 - $13.89 $93,368 - $104,841
7,548 Added 0.6%
1,272,897 $16.5 Million
Q2 2023

Aug 11, 2023
BUY
$11.39 - $13.72 $218,175 - $262,806
19,155 Added 1.54%
1,265,349 $16.1 Million
Q1 2023

May 15, 2023
BUY
$10.73 - $13.6 $529,772 - $671,472
49,373 Added 4.13%
1,246,194 $14 Million
Q4 2022

Feb 13, 2023
BUY
$11.8 - $13.78 $553,254 - $646,089
46,886 Added 4.08%
1,196,821 $15.9 Million
Q3 2022

Nov 14, 2022
BUY
$11.61 - $15.22 $163,178 - $213,917
14,055 Added 1.24%
1,149,935 $13.4 Million
Q2 2022

Aug 12, 2022
BUY
$14.32 - $19.88 $1.9 Million - $2.64 Million
132,856 Added 13.25%
1,135,880 $16.8 Million
Q1 2022

May 13, 2022
BUY
$15.39 - $20.25 $106,206 - $139,745
6,901 Added 0.69%
1,003,024 $19.4 Million
Q4 2021

Feb 11, 2022
BUY
$15.91 - $18.72 $100,933 - $118,759
6,344 Added 0.64%
996,123 $17.2 Million
Q3 2021

Nov 12, 2021
SELL
$13.06 - $17.24 $1.89 Million - $2.5 Million
-144,810 Reduced 12.76%
989,779 $16.5 Million
Q2 2021

Aug 13, 2021
SELL
$11.45 - $13.96 $77,310 - $94,257
-6,752 Reduced 0.59%
1,134,589 $15.2 Million
Q1 2021

May 12, 2021
BUY
$11.06 - $12.87 $1.5 Million - $1.74 Million
135,244 Added 13.44%
1,141,341 $13.6 Million
Q4 2020

Feb 12, 2021
BUY
$9.33 - $12.48 $301,116 - $402,779
32,274 Added 3.31%
1,006,097 $12.5 Million
Q3 2020

Nov 13, 2020
SELL
$10.33 - $14.49 $484,280 - $679,305
-46,881 Reduced 4.59%
973,823 $10.2 Million
Q2 2020

Aug 13, 2020
BUY
$11.49 - $15.26 $244,576 - $324,824
21,286 Added 2.13%
1,020,704 $14.3 Million
Q1 2020

May 14, 2020
BUY
$8.11 - $15.23 $455,165 - $854,768
56,124 Added 5.95%
999,418 $11.8 Million
Q4 2019

Feb 13, 2020
BUY
$10.28 - $14.38 $292,856 - $409,657
28,488 Added 3.11%
943,294 $13.4 Million
Q3 2019

Nov 12, 2019
BUY
$10.05 - $14.55 $215,532 - $312,039
21,446 Added 2.4%
914,806 $9.64 Million
Q2 2019

Aug 14, 2019
BUY
$13.1 - $14.95 $373,638 - $426,403
28,522 Added 3.3%
893,360 $13 Million
Q1 2019

May 14, 2019
BUY
$13.69 - $20.06 $889,288 - $1.3 Million
64,959 Added 8.12%
864,838 $12.1 Million
Q4 2018

Feb 13, 2019
BUY
$13.96 - $18.26 $323,048 - $422,554
23,141 Added 2.98%
799,879 $14 Million
Q3 2018

Nov 13, 2018
BUY
$13.63 - $15.7 $366,469 - $422,125
26,887 Added 3.59%
776,738 $11.8 Million
Q2 2018

Aug 14, 2018
SELL
$13.44 - $17.59 $61,313 - $80,245
-4,562 Reduced 0.6%
749,851 $10.3 Million
Q1 2018

May 15, 2018
SELL
$13.8 - $16.99 $510,544 - $628,562
-36,996 Reduced 4.67%
754,413 $12.6 Million
Q4 2017

Feb 13, 2018
SELL
$11.73 - $14.75 $103,130 - $129,682
-8,792 Reduced 1.1%
791,409 $11.2 Million
Q3 2017

Nov 14, 2017
BUY
$12.06 - $14.12 $1.03 Million - $1.21 Million
85,630 Added 11.98%
800,201 $11.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
714,571
714,571 $9.15 Million

Others Institutions Holding INVA

# of Institutions
228
Shares Held
78.7M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.2B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email